Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial
Chandiwana et al., eBioMedicine, doi:10.1016/j.ebiom.2022.104322
https://c19early.org/chandiwana.html